Adults and Adolescents With Neuroblastoma: An Analysis of the National Cancer Database
Journal of Surgical Oncology · 2025-06 · 131 (7) · 1420-1430
DOI: 10.1002/jso.28076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 08.01.2025. Verfasst von Charbel Chidiac und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Neuroblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Neuroblastoma, the most common extracranial solid tumor in children, is rare in adults. This study compares patient characteristics, disease patterns, and treatments among adults, adolescents, and children with neuroblastoma.
Methods
We queried the National Cancer Database (2004–2019) for neuroblastoma cases. Patient and tumor characteristics, treatments, and 5‐year overall survival (5‐OS) were compared between adults (≥ 18 years), adolescents (10–17 years), and children (0–9 years). Kaplan–Meier curves and Cox regression assessed survival differences.
Results
Among 6350 neuroblastoma patients, 256 (4.0%) were adults, 222 (3.5%) were adolescents, and 5872 (92.5%) were children. Tumors were largest in adolescents (9.7 cm), followed by adults (8.0 cm) and children (6.7 cm) ( p < 0.001). Adults were less likely to have tumors in the adrenal glands (34.0% vs. children: 54.7%, adolescents: 43.2%, p < 0.001) and had lower rates of metastasis (10.9% vs. 19.3% and 19.4%, p < 0.001). Compared to children, adults received less chemotherapy, immunotherapy, and bone marrow transplants ( p < 0.001). 5‐OS was worse in adults (65.8%), followed by adolescents (70.4%) and children (78.2%) ( p < 0.001). After adjustment, adults (aHR: 2.27; 95% CI, 1.71–3.01) and adolescents (aHR: 2.02; 95% CI, 1.54–2.64) had higher hazards of death compared to children.
Conclusions
Adults and adolescents with neuroblastoma have distinct clinical features and lower survival than children, underscoring the need for tailored treatment approaches for older patients. Level of Evidence III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Surgery, Division of Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Oncology, Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Zitieren
APA
Chidiac, C., McDermott, K. M., Ramdat, C., Price, M. D., Greer, J. B., Ladle, B. H., & Rhee, D. S. (2025). Adults and Adolescents With Neuroblastoma: An Analysis of the National Cancer Database. Journal of Surgical Oncology, 131(7), 1420-1430. https://doi.org/10.1002/jso.28076
Vancouver
Chidiac C, McDermott KM, Ramdat C, Price MD, Greer JB, Ladle BH, et al. Adults and Adolescents With Neuroblastoma: An Analysis of the National Cancer Database. Journal of Surgical Oncology. 2025;131(7):1420-1430. doi:10.1002/jso.28076
BibTeX
@article{Chidiac2025,
author = {Chidiac, Charbel and McDermott, Katherine M and Ramdat, Caitlyn and Price, Matthew D and Greer, Jonathan B and Ladle, Brian H and Rhee, Daniel S},
title = {Adults and Adolescents With Neuroblastoma: An Analysis of the National Cancer Database},
journal = {Journal of Surgical Oncology},
year = {2025},
volume = {131},
number = {7},
pages = {1420--1430},
doi = {10.1002/jso.28076}
}
EUVIMED